SERRATIA TÜRLERİNİN İDENTİFİKASYONU, KLİNİK DAĞILIMI, ANTİBİYOTİK DUYARLILIĞI
Serratia spp. özellikle yenidoğan, çocuk ve diğer yoğun bakım üniteleri başta olmak üzere hastane infeksiyonu etkenleri arasında önemli yeri olan bir bakteri grubudur. Çalışmada klinik ve polikliniklerden gönderilen farklı örneklerden izole edilen Serratia marcescens ve diğer Serratia türlerinin klinik kökenleri ve antibiyotik duyarlılık sonuçlarının tartışılması amaçlanmıştır. İki yıllık bir dönem içerisinde kliniklerden ve poliklinikten gönderilen farklı materyallerden infeksiyon etkeni olarak izole edilen Serratia suşlarının identifikasyonu MALDI-TOF-MS (Matrix-assisted laser desorption/ionization- time of flight- mass spectrometry, Bruker Daltonics, ABD), duyarlılık testleri ise Phoenix UNMIC-401/ ID Paneli ve NMIC-400/ID Paneli (Becton Dickinson Diagnostic Instrument Systems, Sparks, Md, ABD) ile yapılmıştır. İzole edilen 105 Serratia suşunun 17’si (% 16) poliklinik, 88’i (% 84) klinik ve yoğun bakım hastalarından izole edilmiş olup 89 suş (% 84.7) S.marcescens, beş suş (% 4.7) Serratia ureilytica, dört suş (% 3.8) Serratia liquefaciens, birer suş da Serratia ficaria, Serratia fonticola ve Serratia plymuthica olarak tanımlanırken dört Serratia cinsine ait izolatın sistem tarafından tür identifikasyonu yapılamamıştır. Toplam örneklerin 51’i (% 49) yoğun bakım ünitelerinden gönderilmiş olup bu sayı içerisinde yenidoğan ve çocuk yoğun bakım ünitelerindeki yoğunluk (% 56.8) dikkat çekicidir. Sonuç olarak ciddi bir hastane enfeksiyonu etkeni olarak bilinen Serratia cinsi bakterilerin antibiyotik duyarlılık sonuçlarını sunarak bu bakteri cinsine dikkat çekmek istenmiştir. Serratia cinsi bakterilerin özellikle yoğun bakım hastalarında, yoğun bakım üniteleri içinde ise önemli oranda çocuk yoğun bakım ünitelerinde enfeksiyonlara yol açtıkları ve daha çok pnömoni, idrar yolu enfeksiyonları, sepsis ve yara yeri enfeksiyonlarına neden oldukları görülmektedir. Aynı zamanda çalışmamızda Serratia türlerine karşı sırayla amikasin (% 97), siprofloksasin (% 95), aztreonam (% 93) ve trimetoprim/sülfametoksazol (% 93) en etkili antibiyotikler olarak tespit edilmiştir.
Identification of Serratia Species, Clinical Distribution, Antibiotic Susceptibility
Serratia spp. is a group of bacteria that has an important place among nosocomial infections, especially neonates, children and other intensive care units. The aim of the study is to discuss the clinical origins and antibiotic susceptibility results of Serratia marcescens and other Serratia species isolated from different material specimens sent from inpatient and outpatient clinics. Identification of Serratia strains isolated from different materials for two years was performed by MALDI-TOF-MS (Matrix-assisted laser desorption/ionization- time of flight- mass spectrometry, Bruker Daltonics, USA) Susceptibility tests were done with Phoenix UNMIC-401 / ID Panel and NMI-400 / ID Panel (Becton Dickinson Diagnostic Instrument Systems, Sparks, Md., USA). 17 (16 %) of 105 Serratia spp. strains were isolated from outpatient clinics, 88 (84 %) were isolated from clinical and intensive care patients. Of these, 89 (84.7 %) were S.marcescens, five (4.7 %) were Serratia ureilytica, four (3.8 %) were Serratia liquefaciens, one were Serratia ficaria, Serratia fonicola and, four of them could not be identified to species level by the system. Fifty one (49 %) of the total samples were sent from intensive care units and the tendency to neonatal and pediatric intensive care units (56.8 %) was remarkable. As a result, by presenting their antibiotic susceptibility results, we want to draw attention to this bacterial genus which are known as one of the agent of serious hospital infections. It is seen that Serratia spp. cause infections especially in intensive care units mostly in pediatric intensive care units and cause pneumonia, urinary tract infections, sepsis and wound infections. We have also identified amikacin (% 97), ciprofloxacin (% 95), aztreonam (% 93) and trimethoprim/sulfamethoxazole (% 93) as the most effective antibiotics against Serratia species in our hospital.
___
- Agyepong N, Govinden U, Ofori AO, Essack SY.
Multidrug-resistant gram negative bacterial infections
in a teaching hospital in Ghana. Antimicrob
Resist Infect Control 2018;7:37.
https://doi.org/10.1186/s13756-018-0324-2
- Annual epidemiological report 2012: Reporting on
2010 surveillance data and 2011 epidemic intelligence
data. European Centre for Disease
Prevention and Control, Stockholm, Sweden.
- Åttman E, Korhonen P, Tammela O, Vuento R, et
al. Serratia marcescens outbreak in a neonatal
intensive care unit was successfully managed by
rapid hospital hygiene interventions and screening. Acta Paediatr. 2018;107(3):425-9.
https://doi.org/10.1111/apa.14132
- Baykan M, Özerol İH, Kart H, Baysal B. Bir
Serratia sepsisi olgusu. Turgut Özal Tıp Merkezi
Derg. 1994;1(3):210-2.
- Bayramoğlu G, Buruk K, Dinç U, Mutlu M, Yılmaz
G, Aslan Y. Yenidoğan yoğun bakım ünitesinde
Serratia marcescens salgınının kısa süreli “PulsedField
Gel’’ elektroforez protokolü ile araştırılması.
ANKEM Derg. 2008;22(Ek 1):54, J Microbiol
Immunol Infect. 2011;44(2):111-5.
- Bilgehan H. Klinik Mikrobiyolojik Tanı, s.430,
Barış yayınları, İzmir (2009).
- Bozkurt H, Güdücüoğlu H, Bayram Y ve ark.
Klinik örneklerden üretilen Serratia cinsi bakterilerin
çeşitli infeksiyonlardaki rolü ve antimikrobiyallere
duyarlılıkları. Van Tıp Derg. 2005;12(3):
182-8.
- Cherkaoui A, Hibbs J, Emonet S, et al. Comparison
of two matrix-assisted laser desorption ionizationtime
of flight mass spectrometry methods with
conventional phenotypic identification for routine
identification of bacteria to the species level. J Clin
Microbiol. 2010;48(4):1169-75.
https://doi.org/10.1128/JCM.01881-09
- Cullen MM, Trail A, Robinson M, Keaney M,
Chadwick PR. Serratia marcescens outbreak in a
neonatal intensive care unit prompting review of
decontamination of laryngoscopes. J Hosp Infect.
2005;59(1):68-70.
https://doi.org/10.1016/j.jhin.2004.08.003
- EUCAST (The European Committee on
Antimicrobial Susceptibility Testing). Breakpoint
tables for interpretation of MICs and zone diameters.
Version 8.0, (2018). http://www.eucast.org
- Garner JS, Jarvis WR, Emori TG, Horan TC,
Hughes JM. CDC definitions for nosocomial infections,
1988. Am J Infect Control 1988;16(3):128-40.
https://doi.org/10.1016/0196-6553(88)90053-3
- Gary W. Procop, Deirdre L. Church, Geraldine S.
Hall, William M. Janda, Elmer W. Koneman, Paul
C. Schreckenberger, Gail L. Woods. Koneman’s
Colour Atlas and Textbook of Microbiology Türkçe
baskısı, 7. baskı. s.17, Hipokrat kitabevi, Ankara
(2017).
- Gary W. Procop, Deirdre L. Church, Geraldine S.
Hall, William M. Janda, Elmer W. Koneman, Paul
C. Schreckenberger, Gail L. Woods. Koneman’s
Colour Atlas and Textbook of Microbiology Türkçe
baskısı, 7. baskı. s.164-5, Hipokrat kitabevi, Ankara
(2017).
- Hasçelik G. Mikrobiyolojik tanıda yeni yöntemler.
ANKEM Derg. 2013;27(Ek 2):154-6.
- Hejazi A, Falkiner FR. Serratia marcescens. J Med
Microbiol. 1997;46(11):903-12.
https://doi.org/10.1099/00222615-46-11-903
- Herra C, Falkiner FR. Serratia marcescens, infectious
disease and antimicrobial agents www.antimicrobe.org/b26.asp
(Erişim tarihi:19.04.2018)
- Kang HY, Kim KY, Kim J, et al. Distribution of
conjugative-plasmid-mediated 16S rRNA methylase
genes among amikacin-resistant
Enterobacteriaceae isolates collected in 1995 to
1998 and 2001 to 2006 at a university hospital in
South Korea and identification of conjugative
plasmids mediating dissemination of 16S rRNA
methylase. J Clin Microbiol. 2008;46(2): 700-6.
https://doi.org/10.1128/JCM.01677-07
- Khanafari A, Assadi MM, Fakhr FA. Review of
prodigiosin, pigmentation in Serratia marcescens.
Online J Biol Sci. 2006;6(1):1-13.
https://doi.org/10.3844/ojbsci.2006.1.13
- Khanna A, Khanna M, Aggarwal A. Serratia
marcescens-A rare oppotunistic nosocomial pathogen
and measures to limit its spread in hospitalized
patients. J Clin Diagn Res. 2013;7(2):243-6.
- Liu D, Zhang LP, Huang SF, et al. Outbreak of
Serratia marcescens infection due to contamination
of multiple-dose vial of heparin-saline solution
used to flush deep venous catheters or peripheral
trocars. J Hosp Infect. 2011;77(2):175-6.
https://doi.org/10.1016/j.jhin.2010.10.003
- Lockhart SR, Abramson MA, Beekmann SE, et al.
Antimicrobial resistance among Gram-negative
bacilli causing infections in intensive care unit
patients in the United States between 1993 and
2004. J Clin Microbio. 2007;45(10):3352-9.
https://doi.org/10.1128/JCM.01284-07
- Matkoski C, Sharp SE, Kiska DL. Evaluation of the
Q Score and Q234 Systems for Cost-Effective and
Clinically Relevant Interpretation of Wound
Cultures. J Clin Microbiol. 2006;44(5):1869-72.
https://doi.org/10.1128/JCM.44.5.1869-1872.2006
- Mills J, Drew D. Serratia marcescens endocarditis:
a regional illness associated with intravenous
drug abuse. Ann Intern Med. 1976;84(1):29-35.
https://doi.org/10.7326/0003-4819-84-1-29
- Nakashima AK, McCarthy MA, Martone WJ,
Anderson RL. Epidemic septic arthritis caused by
Serratia marcescens and associated with a benzalkonium
chloride antiseptic. J Clin Microbiol.
1987;25(6):1014-8.
- Neville SA, LeCordier A, Ziochos H, et al. Utility
of Matrix Assisted Laser Desorption Ionization–
Time of Flight Mass Spectrometry following introduction
for routine laboratory bacterial identification. J Clin Microbiol. 2011;49(8):2980-4.
https://doi.org/10.1128/JCM.00431-11
- Ringrose RE, McKown B, Felton FG, Barclay BO,
Muchmore HG, Rhoades ER. A hospital outbreak
of Serratia marcescens associated with ultrasonic
nebulizers, Ann Intern Med. 1968;69(4):719-29.
https://doi.org/10.7326/0003-4819-69-4-719
- Sader HS, Farrell DJ, Flamm RK, Jones RN.
Antimicrobial susceptibility of Gram-negative
organisms isolated from patients hospitalized in
intensive care units in United States and European
hospitals (2009-2011). Diagn Microbiol Infect Dis.
2014;78(4):443-8.
https://doi.org/10.1016/j.diagmicrobio.2013.11.025
- Samonis G, Vardakas KZ, Maraki S, et al. Resistance
phenotypes and susceptibility of contemporary
Serratia isolates in the university hospital of Crete,
Greece. Infect Dis. 2017;49(11-12):847-53.
https://doi.org/10.1080/23744235.2017.1361546
- Sethuraman S, Arunachalam A, Karthikeyan M,
Kumar SA, Manidipa S, Senthilraj R. Antimicrobial
sensitivity profile of Serratia marcescens strains
isolated in government general hospital,
Nagapatinam, Tamilnadu, India. Int J Preclinic
Pharm Res. 2011;2(1):7-11.
- Soltani J, Poorabbas B, Miri N, Mardaneh J. Health
care associated infections, antibiotic resistance
and clinical outcome: a surveillance study from
Sanandaj, Iran. World J Clin Cases 2016;4(3):63-
70.
https://doi.org/10.12998/wjcc.v4.i3.63
- Stock I, Grueger T, Wiedemann B. Natural antibiotic
susceptibility of strains of Serratia marcescens
and the S.liquefaciens complex: S.liquefaciens
sensu stricto, S.proteamaculans and S.grimesii. Int
J Antimicrob Agents 2003;22(1):35-47.
https://doi.org/10.1016/S0924-8579(02)00163-2
- Tanaka T, Takahashi H, Kobayashi JM, Ohyama T,
Okabe N. A nosocomial outbreak of febrile bloodstream
infection caused by heparinized-saline
contaminated with Serratia marcescens, Tokyo,
2002. Jpn J Infect Dis. 2004;57(5):189-92.
- Tıraş Ü, Erdeve Ö, Çamurdan O, Dallar Y. Serratia
marcescens: yenidoğan için ölüme sebebiyet veren
ciddi bir ajan. T Klin J Med Sci. 2002;22(6):571-3.
- Us E, Kutlu HH, Tekeli A, Öcal D, Çırpan S,
Memikoğlu KO. Wound and soft tissue infections
of Serratia marcescens in patients receiving wound
care: a health care-associated outbreak. Am J
Infect Control 2017;45(4):443-7.
https://doi.org/10.1016/j.ajic.2016.11.015
- Van Veen SQ, Claas EC, Kuijper EJ. Highthroughhput
identification of bacteria and yeast
by matrix-assisted laser desorption ionization
–time of flight mass spectrometry in conventional
medical microbiology laboratories. J Clin
Microbiol. 2010;48(3):900-7.
https://doi.org/10.1128/JCM.02071-09